Literature DB >> 24826276

Biventricular noncompaction cardiomyopathy in a patient presenting with new onset seizure: case report.

Oghenerukevwe Odiete1, Ramanna Nagendra2, Mark A Lawson1, Henry Okafor2.   

Abstract

Ventricular noncompaction (VNC) of the myocardium is a rare genetic cardiomyopathy caused by a disorder during endocardial morphogenesis and could be accompanied by life-threatening complications. The major clinical manifestations of VNC are heart failure, arrhythmias, and embolic events. The left ventricle is the most commonly reported affected site, but a few cases of right ventricular involvement have also been reported. We report a case of biventricular noncompaction cardiomyopathy in a 31-year-old woman presenting with a new onset seizure. On the second day of her telemetry-monitored hospitalization, she suffered a witnessed ventricular fibrillation arrest requiring emergency direct-current cardioversion and induced hypothermia. Transthoracic echocardiography (TTE) showed isolated left ventricular (LV) noncompaction and depressed LV systolic function. Subsequent cardiac magnetic resonance imaging (MRI) revealed both left and right ventricular noncompaction. This unusual presentation highlights the importance of a complete and thorough evaluation of patients even when presenting with apparently noncardiac symptom(s).

Entities:  

Year:  2012        PMID: 24826276      PMCID: PMC4008239          DOI: 10.1155/2012/924865

Source DB:  PubMed          Journal:  Case Rep Cardiol        ISSN: 2090-6404


1. Introduction

Ventricular noncompaction (VNC) of the myocardium is a rare genetic cardiomyopathy that is believed to arise from arrested endomyocardial development during embryogenesis [1]. It is a rare idiopathic cardiomyopathy with an incidence of about 0.05% [2, 3]. VNC is classified by the American Heart Association as a primary genetic cardiomyopathy [1] and is characterized by an altered myocardial wall with prominent trabeculae and deep intertrabecular recesses. This results a thickened bilayer of compacted and noncompacted myocardium [4], caused by the arrest of the normal process of endomyocardial morphogenesis. The normal process of trabeculation has been shown to be dependent upon secretion of neuregulin growth factors from the endocardium. Angiogenic factors, such as vascular endothelial growth factor and angiopoietin-1, may also be critical for normal trabeculae formation [5, 6]. The major clinical manifestations of VNC are heart failure, arrhythmias, sudden cardiac death, cardioembolic events, and syncope [7-9]. To our knowledge, seizures have not been previously reported as a manifestation of this condition. Here, we report a case of biventricular noncompaction cardiomyopathy in a young female presenting with new-onset tonic-clonic seizure.

2. Case Presentation

A 31-year-old woman presented with a witnessed loss of consciousness while driving. The episode lasted for about five-to-ten minutes and was associated with tonic-clonic seizure-like movement. There was no urinary or bowel incontinence. She had no history of seizures, arrhythmias, or family history of sudden cardiac death. Physical exam was remarkable only for a 2/6 systolic ejection murmur loudest at the left midsternal border on cardiac auscultation. The laboratory results were within normal limits. Electrocardiogram (ECG) showed sinus rhythm with occasional premature ventricular complexes. An electroencephalogram (EEG) and a head-computed tomography (CT) scan were unrevealing. In the course of the workup, the patient suffered a ventricular fibrillation cardiac arrest requiring defibrillation and induced hypothermia for resuscitation. She recovered without neurologic deficits. Cardiac evaluation with echocardiogram (Figure 1) showed depressed left ventricular systolic function (ejection fraction (EF) of 30–35%), biatrial enlargement, and increased left ventricular (LV) wall thickness. The left ventricular wall showed marked trabeculation within the inner layer of myocardium consistent with LV noncompaction cardiomyopathy. Contrast study showed blood flow through the trabeculated noncompact inner layer to the outer compact layer. Cardiac MRI (Figure 2) demonstrated the prominent LV trabeculation pattern that was noted on TTE, which forms the classic spongiform appearance on the distal one-third of the LV cavity. In addition, an equally prominent trabeculation pattern was seen in the right ventricle (RV) involving the distal one-third of the RV. Since other MRI features of arrhythmogenic RV dysplasia were absent, the MRI findings were consistent with biventricular noncompaction. A single-lead ICD was implanted and the patient was later discharged in stable condition.
Figure 1

Echocardiogram of the heart. (a) Apical view demonstrating marked trabeculation of the left ventricular apex (white arrow). (b) It shows contrast agent visualized between the ventricular trabeculations. RA: right atrium; LA: left atrium; LV: left ventricle; RV: right ventricle.

Figure 2

Cardiac MRI of the heart. ((a) and (b)) Cardiac MRI of the LV showing prominent muscular trabeculations (asterisk) and spongiform appearance of the ventricular cavities. (c) Short axis cardiac MRI image through the distal RV and LV, demonstrating trabeculations filling the ventricular cavity.

3. Discussion

VNC of the myocardium is a rare genetic cardiomyopathy. The left ventricle is more frequently involved, but biventricular involvement, as in this case, is rarely encountered [10, 11]. What made our patient unique were not only the individual diagnostic findings, but also the aggregate clinical picture. Oechslin et al.[7] demonstrated in a follow-up study of 34 patients that the most important clinical manifestations of VNC were heart failure (53%), ventricular tachycardia (41%), sudden cardiac death (35%), syncope (18%), and embolic events (24%). Our patient presented solely with a tonic-clonic seizure-like activity and a normal EKG and EEG, but later experienced an in-hospital ventricular fibrillation cardiac arrest. Among all the presenting symptom of VNC, the most common reason for referral was heart failure, [6, 7] with one-third of these patients having NYHA class III/IV at time of diagnosis [12]. Our patient did not have signs or symptoms of heart failure on presentation. However, this does not exclude the fact that she had an asymptomatic cardiomyopathy. Although tonic-clonic seizure-like activity was the only presenting symptom given the extensive structural heart disease, it is plausible that this patient likely had a ventricular arrhythmic event (since the EEG and ECG were unrevealing) leading to generalized cerebral hypoxia, and thus the tonic-clonic seizure activity. The resulting motor activity has been attributed to a decreased cerebral blood flow [13], which results in generalized cerebral hypoxia and thus mimicking epileptic seizures [13-15]. Furthermore, the abnormal motor activity of syncope due to malignant ventricular arrhythmias [16] can also mimic epileptic seizures. Schott et al. [17] identified cardiac arrhythmias in 20% of the patients referred with idiopathic epilepsy. Patients with VNC are at an increased risk for thromboembolic events [18]. However, in the absence of atria fibrillation or LV systolic dysfunction, the risk for cardioembolic event is rare [19]. Seizure may be an associated complication following an acute stroke [20]. Even though our patient had a negative CT scan of the head, it is conceivable that a thromboembolic event was a plausible cause for the seizure. Although left ventricular noncompaction is more common, the improved imaging capabilities of cardiac MRI provide opportunity for better characterization of right ventricular involvement. Echocardiography has a crucial role in the diagnosis of VNC, but cardiac MRI, contrast ventriculography, and computed tomography could also be utilized during assessment, especially in patients with poor image quality on echocardiography [21, 22], in order to rule out other cardiac pathological involvement. Borreguero et al. [23] suggested the potential role of cardiac MRI in the evaluation of the RV with noncompacted myocardium. Our patient represents an important example of biventricular noncompaction cardiomyopathy, in which cardiac MRI aided the diagnosis. In conclusion, VNC is an uncommon disorder accompanied by life-threatening complications. Its unusual presentation highlights the importance of a complete and thorough workup of patients presenting with apparently noncardiac symptom(s). Data is limited on specific therapy for VNC, but it is recommended that medical management be tailored towards the clinical manifestations, and standard guidelines should be applied for patients with reduced LVEF, and heart failure with preserved systolic function [24], in the setting of VNC. Patients with VNC, who meet standard criteria for anticoagulation, should also be managed according to standard guidelines [25]. In addition, periodic holter monitoring may be used to assess the risk for asymptomatic arrhythmias. Finally, patients with VNC should receive implantable cardioverter-defibrillator (ICD) therapy according to standard indications for primary and secondary prevention of sudden cardiac arrest [26, 27].
  26 in total

1.  Noncompaction of ventricular myocardium and arrhythmias.

Authors:  F Duru; R Candinas
Journal:  J Cardiovasc Electrophysiol       Date:  2000-04

2.  Isolated noncompaction of the ventricular myocardium: clinical and molecular aspects of a rare cardiomyopathy.

Authors:  Eduardo Zambrano; Stephen J Marshalko; C Carl Jaffe; Pei Hui
Journal:  Lab Invest       Date:  2002-02       Impact factor: 5.662

3.  Images in cardiovascular medicine. Diagnosis of isolated noncompaction of the myocardium by magnetic resonance imaging.

Authors:  Luis J J Borreguero; Roberto Corti; Rafael F de Soria; Julio I Osende; Valentin Fuster; Juan J Badimon
Journal:  Circulation       Date:  2002-05-28       Impact factor: 29.690

4.  ACC/AHA/ESC 2006 guidelines for management of patients with ventricular arrhythmias and the prevention of sudden cardiac death: a report of the American College of Cardiology/American Heart Association Task Force and the European Society of Cardiology Committee for Practice Guidelines (Writing Committee to Develop Guidelines for Management of Patients With Ventricular Arrhythmias and the Prevention of Sudden Cardiac Death).

Authors:  Douglas P Zipes; A John Camm; Martin Borggrefe; Alfred E Buxton; Bernard Chaitman; Martin Fromer; Gabriel Gregoratos; George Klein; Arthur J Moss; Robert J Myerburg; Silvia G Priori; Miguel A Quinones; Dan M Roden; Michael J Silka; Cynthia Tracy; Sidney C Smith; Alice K Jacobs; Cynthia D Adams; Elliott M Antman; Jeffrey L Anderson; Sharon A Hunt; Jonathan L Halperin; Rick Nishimura; Joseph P Ornato; Richard L Page; Barbara Riegel; Silvia G Priori; Jean-Jacques Blanc; Andrzej Budaj; A John Camm; Veronica Dean; Jaap W Deckers; Catherine Despres; Kenneth Dickstein; John Lekakis; Keith McGregor; Marco Metra; Joao Morais; Ady Osterspey; Juan Luis Tamargo; José Luis Zamorano
Journal:  J Am Coll Cardiol       Date:  2006-09-05       Impact factor: 24.094

5.  Natural history and familial characteristics of isolated left ventricular non-compaction.

Authors:  Ross T Murphy; Rajesh Thaman; Juan Gimeno Blanes; Deirdre Ward; Elias Sevdalis; Efi Papra; Anatoli Kiotsekoglou; Anatoli Kiotsekolglou; Maria T Tome; Denis Pellerin; William J McKenna; Perry M Elliott
Journal:  Eur Heart J       Date:  2004-11-30       Impact factor: 29.983

6.  ACC/AHA/HRS 2008 Guidelines for Device-Based Therapy of Cardiac Rhythm Abnormalities: a report of the American College of Cardiology/American Heart Association Task Force on Practice Guidelines (Writing Committee to Revise the ACC/AHA/NASPE 2002 Guideline Update for Implantation of Cardiac Pacemakers and Antiarrhythmia Devices): developed in collaboration with the American Association for Thoracic Surgery and Society of Thoracic Surgeons.

Authors:  Andrew E Epstein; John P DiMarco; Kenneth A Ellenbogen; N A Mark Estes; Roger A Freedman; Leonard S Gettes; A Marc Gillinov; Gabriel Gregoratos; Stephen C Hammill; David L Hayes; Mark A Hlatky; L Kristin Newby; Richard L Page; Mark H Schoenfeld; Michael J Silka; Lynne Warner Stevenson; Michael O Sweeney; Sidney C Smith; Alice K Jacobs; Cynthia D Adams; Jeffrey L Anderson; Christopher E Buller; Mark A Creager; Steven M Ettinger; David P Faxon; Jonathan L Halperin; Loren F Hiratzka; Sharon A Hunt; Harlan M Krumholz; Frederick G Kushner; Bruce W Lytle; Rick A Nishimura; Joseph P Ornato; Richard L Page; Barbara Riegel; Lynn G Tarkington; Clyde W Yancy
Journal:  Circulation       Date:  2008-05-15       Impact factor: 29.690

7.  Contemporary definitions and classification of the cardiomyopathies: an American Heart Association Scientific Statement from the Council on Clinical Cardiology, Heart Failure and Transplantation Committee; Quality of Care and Outcomes Research and Functional Genomics and Translational Biology Interdisciplinary Working Groups; and Council on Epidemiology and Prevention.

Authors:  Barry J Maron; Jeffrey A Towbin; Gaetano Thiene; Charles Antzelevitch; Domenico Corrado; Donna Arnett; Arthur J Moss; Christine E Seidman; James B Young
Journal:  Circulation       Date:  2006-03-27       Impact factor: 29.690

8.  Angiographic diagnosis, prevalence and outcomes for left ventricular noncompaction in children with congenital cardiac disease.

Authors:  Marina L Hughes; Bendix Carstensen; James L Wilkinson; Robert G Weintraub
Journal:  Cardiol Young       Date:  2006-12-22       Impact factor: 1.093

9.  Early seizures in first-ever acute stroke patients in India: incidence, predictive factors and impact on early outcome.

Authors:  R P Goswami; P S Karmakar; A Ghosh
Journal:  Eur J Neurol       Date:  2012-06-11       Impact factor: 6.089

10.  Frequency of stroke and embolism in left ventricular hypertrabeculation/noncompaction.

Authors:  Claudia Stöllberger; Gerhard Blazek; Christoph Dobias; Aileen Hanafin; Christian Wegner; Josef Finsterer
Journal:  Am J Cardiol       Date:  2011-07-23       Impact factor: 2.778

View more
  1 in total

1.  Sudden cardiac death with triple pathologies: A case report.

Authors:  R Razuin; F Nurquin; M N Shahidan; M N Julina
Journal:  Egypt Heart J       Date:  2017-03-06
  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.